Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data

Non-alcoholic steatohepatitis (NASH) is associated with significant morbidity and mortality due to liver cirrhosis, liver failure, and hepatocellular carcinoma, and represents a leading indication for liver transplantation in the United States (U.S.). A growing spectrum of novel therapies are curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz Soto, Maria Paula, Lim, Joseph K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434517/
https://www.ncbi.nlm.nih.gov/pubmed/32884369
http://dx.doi.org/10.2147/HMER.S230613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434517/
https://www.ncbi.nlm.nih.gov/pubmed/32884369
http://dx.doi.org/10.2147/HMER.S230613

Ejemplares similares